Disease clearance after 16 weeks of treatment with vedolizumab in patients with moderate to severe Ulcerative Colitis: An interim analysis from the VERDICT trialV. Jairath,G. Zou,S. Adsul,J. F. Colombel, G. R. D'Haens, M. Freire, G. W. Moran, L. Peyrin-Biroulet,W. J. Sandborn,S. Sebastian,S. Travis,S. Vermeire,J. Hanzel,C. Ma,R. Sedano, P. Sheridan, N. Arya,M. Beaton,P. Bossuyt,S. Danese, D. Green, W. Harlan, M. Horynski, J. Kierkus, A. Kopon, M. Klopocka, R. Petroniene, M. S. Silverberg, L. Wolanski, B. G. FeaganJOURNAL OF CROHNS & COLITIS（2024）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
